| ²é¿´: 1510 | »Ø¸´: 0 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
arqiu½ð³æ (ÕýʽдÊÖ)
|
[½»Á÷]
ÃÀ¹ú FDA GLP ÈÏ֤ȫÌ×Åàѵ
|
||
|
ת·¢Ò»ÐÅÏ¢£¬Ï£Íû¶Ô´ó¼ÒÓÐÓà www.chinalifescience.org Special Track: U.S. FDA GLP Track by MPI Research Chairpersons: President Bill Harrison, Dr. Honggang Bi 8:30-8:35 Bill Harrison, President & COO, MPI Research -Introduction & Overview of MPI GLP- 8:35-9:00 Matt Foster, Associate Director, Corporate GLPs, MPI Research -GLP-Protocol, Personnel & Study Conduct- 9:00-9:25 Beth Galt, Manager of Compliance, MPI Research -GLP-Equipment, Facilities, Validation- 9:25-9:50 Maryann Scott, Director of Regulatory Affairs, MPI Research -GLP-Records & Reports- 9:50-10:15 Ben Culp, Sr. Director of Laboratory Operations, MPI Research -GLP-Laboratory Management Perspective of GLPs- |
» ²ÂÄãϲ»¶
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ2È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ161È˻ظ´
ÖйúÒ½Ò©ÐÐÒµ·¢Õ¹ÏÖ×´£º±ê×¼Æ·ÍÆ¶¯Ò©Æ·¼ì²âˮƽÌáÉý
ÒѾÓÐ1È˻ظ´
26É격×Ô¼ö
ÒѾÓÐ12È˻ظ´
±ê׼ƷµÄ´¿¶È¶ÔÓÚÒ©Æ·ÖÊÁ¿µÄÓ°ÏìÓжà´ó£¿
ÒѾÓÐ0È˻ظ´
ÈçºÎÖÆ±¸·ûºÏ¼¼ÊõÒªÇóµÄÒ©Æ·±ê׼Ʒ£¿
ÒѾÓÐ0È˻ظ´
¶ÔÕÕÆ·ÔÚÒ©Æ·Ñз¢ÖеIJ»¿É»òȱÐÔ
ÒѾÓÐ0È˻ظ´
±ê׼ƷµÄ·ÖÀàºÍÓÃ;£¬ÄãÖªµÀ¶àÉÙ£¿
ÒѾÓÐ0È˻ظ´
SUES&NERCN¿ÎÌâ×é½ÓÊÜ˶ʿÉúµ÷¼Á (ѧ˶1Ãû+ר˶1Ãû)
ÒѾÓÐ0È˻ظ´















»Ø¸´´ËÂ¥